Condition: Esophageal Squamous Cell Carcinoma · Gastric Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma · Sponsor: iOMEDICO AG
The registry aims to collect and analyse information on the antineoplastic treatment of patients with metastatic esophageal, gastric or gastroesophageal junction cancer, treated in palliative intention in daily routine practice in Germany.
This description comes directly from the study's public registry record.
Adrian Binninger · +49 761 152 42 - 0 · info@iomedico.com
Always discuss trial participation with your own doctor first.
| Multiple sites, Gemany | Multiple Locations, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04290806